Qihang Li

发表

Expansion of the scaffold diversity for the development of highly selective butyrylcholinesterase (BChE) inhibitors: Discovery of new hits through the pharmacophore model generation, virtual screening and molecular dynamics simulation.

Q. Guo, Wenyuan Liu, F. Feng, 2019, Bioorganic chemistry.

Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases.

Ying Chen, Q. Guo, Wenyuan Liu, 2019, European journal of medicinal chemistry.

N-Benzyl Benzamide Derivatives as Selective Sub-Nanomolar Butyrylcholinesterase Inhibitors for Possible Treatment in Advanced Alzheimer's Disease.

W. Li, Wenyuan Liu, F. Feng, 2022, Journal of medicinal chemistry.

Design, synthesis and evaluation of fused hybrids with acetylcholinesterase inhibiting and Nrf2 activating functions for Alzheimer's disease.

Wenyuan Liu, F. Feng, Y. Qiao, 2022, European journal of medicinal chemistry.

Discovery and biological evaluation of a novel highly potent selective butyrylcholinsterase inhibitor.

Wenyuan Liu, F. Feng, Shuaishuai Xing, 2020, Journal of medicinal chemistry.

Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with neuroprotection as potential therapeutic agent for Alzheimer's disease.

Wenyuan Liu, F. Feng, Haopeng Sun, 2020, Bioorganic & medicinal chemistry.

Discovery of a Selective 6-Hydroxy-1, 4-Diazepan-2-one Containing Butyrylcholinesterase Inhibitor by Virtual Screening and MM-GBSA Rescoring

Xin Lu, Haopeng Sun, K. H. Hong, 2020, Dose-response : a publication of International Hormesis Society.

p62/SQSTM1, a Central but Unexploited Target: Advances in its Physiological/Pathogenic Functions and Small Molecular Modulators.

Ying Chen, Wenyuan Liu, F. Feng, 2020, Journal of medicinal chemistry.

Computational design of binder as the LC3-p62 protein-protein interaction.

Wenyuan Liu, F. Feng, Haopeng Sun, 2021, Bioorganic chemistry.

Small molecule KDM4s inhibitors as anti-cancer agents

F. Feng, Q. Hu, Kai Gu, 2018, Journal of enzyme inhibition and medicinal chemistry.

Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors.

Q. Guo, Wenyuan Liu, F. Feng, 2019, Bioorganic chemistry.

Discovery, molecular dynamic simulation and biological evaluation of structurally diverse cholinesterase inhibitors with new scaffold through shape-based pharmacophore virtual screening.

Wenyuan Liu, F. Feng, Xin Lu, 2019, Bioorganic chemistry.

Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer’s Diseases

Zhongwei Huang, Yan Guo, Zongliang Liu, 2020, Molecules.

In silico approaches using pharmacophore model combined with molecular docking for discovery of novel ULK1 inhibitors.

Q. Guo, F. Feng, Li Zhao, 2021, Future medicinal chemistry.